Cargando…
Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019
BACKGROUND: There is growing concern about the potential harmful effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in patients with coronavirus disease 2019 (COVID-19) and cardiovascular diseases (CVDs). The aim of this study was to evaluate the...
Autores principales: | Bae, Seongman, Kim, Ju Hyeon, Kim, Ye-Jee, Lim, Joon Seo, Yun, Sung-Cheol, Kim, Young-Hak, Lee, Sang-Oh, Kim, Sung-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665750/ https://www.ncbi.nlm.nih.gov/pubmed/33235892 http://dx.doi.org/10.1093/ofid/ofaa519 |
Ejemplares similares
-
Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: A multicenter study
por: Son, Hyo-Ju, et al.
Publicado: (2021) -
Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea
por: Bae, Seongman, et al.
Publicado: (2021) -
Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia
por: Lee, Hae-Young, et al.
Publicado: (2021) -
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
por: Kim, Jin Yong, et al.
Publicado: (2022) -
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)